GCG and type 2 diabetes mellitus: A novel approach to control diabetes is based on the use of glucagon-like peptide-1 (GLP-1), an incretin/gut hormone, which has been shown to reduce postprandial and fasting glycemia in type 2 diabetes mellitus (T2DM) [13,14].